• Our Team


     Don Durden, MD, PhDScientific Advisor: Donald L Durden, MD, PhD

    Dr. Durden is a physician-scientist and Associate Director of Moores UCSD Cancer Center. He is codirector of MCC and Rady Children‘s Hospital biorepository and center for personalize oncology. His laboratory is focused on the study of PTEN and PI-3 kinase in cancer and human disease.  He has been involved in drug discovery, development and clinical and basic cancer research for almost 20 years.He has been continuously funded by the NIH for past 20 years. His laboratory was the first laboratory to demonstrate that PTEN controls tumor induced angiogenesis an observation which lead to his efforts to be the first laboratory to show antitumor activity of PI-3 kinase inhibitory molecule ultimately lead to the development of one of the first PI-3 kinase inhibitors, SF1126 to enter human clinical trials.


    Joe Garlich, PhDCSO: Joseph R. Garlich, PhD 

    Over 25 years of experience as a multi-discipline industrial scientist, successful inventor and director of drug discovery and development; over 25 US patents and 4 first-in-man new molecular entities developed to clinical state evaluation.



    Guillermo A Morales, PhD, MBAChief Business Officer & Director of Research: Guillermo A. Morales, PhD, MBA

    Over 20 years of experience in medicinal chemistry, high-throughput synthesis, chemoinformatics, computer-aided drug design, R&D pipeline creation, and intellectual property management in small, medium and large companies serving at director and CEO level positions; 6 patents and Editor-in-Chief of the journal Molecular Diversity.